NCT06467110View on ClinicalTrials.gov

Safety and Effectiveness Study of SQ-Kyrin TMVr System for Degenerated Mitral Regurgitation

NAEnrolling by invitationINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

October 15, 2021

Primary Completion Date

December 15, 2024

Study Completion Date

December 15, 2028

Conditions
Degenerated Mitral Regurgitation
Interventions
DEVICE

transcatheter mitral valve clip delivery system and steerable guide catheter (Shenqi Medical)

The principle of this product is the transcatheter interventional edge-to-edge repair technology (edge-to-edge repair). The core technology is to treat the regurgitation by edge-to-edge suturing the mitral valve. The double holes are set in the mitral valve (A2/P2 zone) or the edges in A1/P1 or A3/P3 zones are apposed and closed to treat regurgitation.

Trial Locations (1)

123005

General Hospital of Northern Theater Command, PLA, Shenyang

All Listed Sponsors
lead

Shanghai Shenqi Medical Technology Co., Ltd

INDUSTRY